Delivery Order SPE2DB20D3101-SPE2DB22FJ4H0

Award Date 4/11/22
Potential Completion Date 4/12/22
Potential Value $3.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Latuda 60 mg tablets to the Defense Logistics Agency (DLA). The $2,896.95 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 30, 2024 with a completion date of July 31, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a broad...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,127.97 firm fixed-price delivery order is for the supply of 80 mg Latuda tablets. The contract has an ultimate completion date of November 8, 2024 and does not utilize a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $2,849.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract is a delivery order for the supply of Latuda 60 mg tablets. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Latuda 120 mg tablets. The contract has a ceiling value of $2,548.62 and a period of performance through August 25, 2023. It is a firm-fixed-price delivery order contract, with no set-aside requirements indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $2,235.71 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of LATUDA 40 MG TABLET 30S, a specialty pharmaceutical product, with a completion date of January 24, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this...
This is a $3,370.58 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4567201571 LATUDA 80 MG TABLET 30S, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,572.93 firm-fixed-price contract is for the delivery of Latuda 80 mg tablets, a specialty medication used to treat mental health conditions. The contract has an ultimate completion date of June 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,438.88 firm fixed-price delivery order is for the supply of Latuda 40 mg tablets. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,406.02 firm fixed-price delivery order is for the supply of LATUDA 80 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $8,496.02, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LATUDA 20 MG TABLET 30S, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FJ4H0
    Delivery Order

This federal contract award is for the delivery of LATUDA 120 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,749.94 delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 11, 2022, with an ultimate completion date of April 12, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation.

AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit pharmaceutical distribution company. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.

Generated 2/27/25, 12:01 PM